Skip to main content

Table 5 Comparison of final pathological carcinoma risks based on endometrial sampling methods

From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy

Endometrial sampling pathology Carcinoma on final pathology Endometrial sampling method P
D&C (n = 100) Aspiration biopsy (n = 150)
Hyperplasia without atypia No 55 (98.2) 58 (93.5) 0.368*
Yes 1 (1.8) 4 (6.5)
Atypical hyperplasia No 30 (68.2) 51 (58.0) 0.255
Yes 14 (31.8) 37 (42.0)
Total No 85 (85.0) 109 (72.7) 0.022
Yes 15 (15.0) 41 (27.3)
  1. Data are n (%) unless otherwise specified
  2. * Fisher’s exact test for hyperplasia without atypia
  3. D&C Dilatation and curettage